The pre-selection of four candidates has been completed on 31.07.2020 by Special Secretariat for Public –
Private Partnerships (PPPs) of the Greek Ministry of Economy and Development for the PPP project “Precision Medicine Infrastructure Project of the Biomedical Research Foundation of the Academy of Athens”. PPP project is supported by EBRD. A phase is completed with the prequalification of 4 candidates:
1. GEK TERNA S.A.
2. AKTOR CONCESSIONS S.A.
3. AVAX S.A.
4. INTRAKAT CONSTRUCTION S.A.
Source of information: Special Secretariat for Public –
Private Partnerships (PPPs), Greek Ministry of Economy and Development.
This is the first time that the Bank is supporting a PPP project in Greece. The venture includes the construction, acquisition of equipment and facility management of a new building for the provision of specialised services in the field of personalised medicine. The new facilities will house a state-of-the-art laboratory that meets high-tech specifications, in area totalling 20,000 m².
Furthermore, the project includes the renovation of the Loverdeion building, in order to create a unit for clinical trials of generic drugs. The total investment is estimated to be approximately €52 million.
The EBRD will cover the costs of technical assistance in the organisation of this PPP project as well as the cost of preparing fair and transparent tenders in order to attract the participation of private investors.
The BRFAA is a non-profit institute dedicated to understanding, treating and preventing human diseases, such as diabetes, cancer, Alzheimer’s and cardiomyopathies, through biomedical research. Established by the Academy of Athens, the foundation provides state-of-the-art facilities for conducting internationally competitive biomedical research and works with more than 250 postdoctoral fellows, laboratory technicians and PhD students.